Facts on Q1 Diagnostic Coverage & Reimbursement Conference West

XiFin, the health information technology company, is excited to announce our participation in the 12^th Semi-Annual Q1 Diagnostic Coverage & Reimbursement Conference West which is set to take place February 6^th thru the 7^th in San Diego, CA. With so many industry leaders interacting, there is no better place to learn about critical issues impacting the payment of diagnostic technologies.

According to Q1 Productions, this year the “focus is set on defining value of diagnostics and evidence to demonstrate clinical utility and cost benefits from the payors perspective.”

XiFin’s Executive Vice President and General Manager of Diagnostic Services, Kyle Fetter will be a presenter. Look-out for some interesting healthcare system outreach lab trends in Kyle’s presentation on clarifying the shifts in labs’ approach to commercialization and coverage for novel diagnostics.  Some of these trends include:

• How new regulations, pricing and prior authorization hurdles are impacting the industry and what labs are doing to prepare
• Innovative ways that novel diagnostic companies are challenging old coverage paradigms
• Outreach programs gaining, if not holding their own, when compared against the national labs on a market share basis
• Average operating margins remain at or above historic levels
• Strengths of healthcare systems-based outreach programs remain
• Need for rapid turn-around time, quality, and customer service

When asked about the importance of this conference for the lab industry Kyle highlighted, “It’s a great way to share and learn new information with thought leaders in our industry, conferences like this help everyone better understand the environment of the market.”

If you would like to arrange a time to meet up with XiFin at this conference fill out this form. You can also register to secure your spot at the Q1 conference, here.